Celmatix is a personalized medicine company that uses big data and predictive analytics to help individuals who are struggling to have a baby make informed decisions. Founded in 2009 and based in New York City, Celmatix is disrupting the way women approach their lifelong fertility journey by empowering them through science and technology. The company’s flagship Polaris product, in use at top fertility clinics across the country, is the world’s first analytics platform for optimizing fertility. Celmatix also has an active research and development program dedicated to decoding the genetic basis of fertility potential.
New York, US
78 (est)+2%
Celmatix was founded in 2009 and is headquartered in New York, US

Celmatix Locations

New York, US

Celmatix Metrics

Celmatix Summary

Founding Date


Total Funding

$18.3 M

Latest funding size

$4.8 M

Time since last funding

8 months


Celmatix's latest funding round of $4.8 M was in April 2016. In total, Celmatix has raised $18.3 M.
34% of current employees of Celmatix are female and 66% are male.

Celmatix Online Presence

Celmatix Company Life

You may also be interested in